Literature DB >> 26651394

Genetics of attention-deficit/hyperactivity disorder: an update.

Glaucia Chiyoko Akutagava-Martins1, Luis Augusto Rohde2,3, Mara Helena Hutz1.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder affecting children, adolescents, and adults. The prevalence is estimated at 5 to 7% of school-aged children and 2.5 to 5% of adults. The phenotype is complex and heterogeneous, presenting variable clinical features, developmental course, and outcome. The genetic susceptibility to ADHD is attributed to both common and rare variants from a broad range of genes related mainly to neurotransmission and neurodevelopment pathways. However, it has been difficult to identify the genetic risk variants that account for the high heritability of this disorder. In this paper, we present recent findings from molecular genetics studies on both child and adult ADHD. Challenges and future directions for ADHD genetic studies are reviewed and discussed.

Entities:  

Keywords:  ADHD; CNVs; GWAS; genetics; pathway analysis; polygenic risk score analysis; susceptibility

Mesh:

Year:  2016        PMID: 26651394     DOI: 10.1586/14737175.2016.1130626

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  25 in total

1.  Knockout of latrophilin-3 in Sprague-Dawley rats causes hyperactivity, hyper-reactivity, under-response to amphetamine, and disrupted dopamine markers.

Authors:  Samantha L Regan; Jillian R Hufgard; Emily M Pitzer; Chiho Sugimoto; Yueh-Chiang Hu; Michael T Williams; Charles V Vorhees
Journal:  Neurobiol Dis       Date:  2019-06-06       Impact factor: 5.996

2.  Prenatal and perinatal factors associated with ADHD risk in schoolchildren: EPINED epidemiological study.

Authors:  Joana Roigé-Castellví; Paula Morales-Hidalgo; Núria Voltas; Carmen Hernández-Martínez; Georgette van Ginkel; Josefa Canals
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-04-02       Impact factor: 4.785

3.  Attention deficit hyperactivity disorder pharmacotherapy in Slovenian adults: a population-based study.

Authors:  Matej Stuhec; Igor Locatelli
Journal:  Int J Clin Pharm       Date:  2018-02-21

4.  ADGRL3 rs6551665 as a Common Vulnerability Factor Underlying Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.

Authors:  Djenifer B Kappel; Jaqueline B Schuch; Diego L Rovaris; Bruna S da Silva; Diana Müller; Vitor Breda; Stefania P Teche; Rudimar S Riesgo; Lavínia Schüler-Faccini; Luís A Rohde; Eugenio H Grevet; Claiton H D Bau
Journal:  Neuromolecular Med       Date:  2019-01-16       Impact factor: 3.843

5.  Prenatal antibiotic exposure and risk of attention-deficit/hyperactivity disorder: a population-based cohort study.

Authors:  Amani F Hamad; Silvia Alessi-Severini; Salaheddin Mahmud; Marni Brownell; I Fan Kuo
Journal:  CMAJ       Date:  2020-05-19       Impact factor: 8.262

6.  Association of Hypertensive Disorders of Pregnancy With Risk of Neurodevelopmental Disorders in Offspring: A Systematic Review and Meta-analysis.

Authors:  Gillian M Maher; Gerard W O'Keeffe; Patricia M Kearney; Louise C Kenny; Timothy G Dinan; Molly Mattsson; Ali S Khashan
Journal:  JAMA Psychiatry       Date:  2018-08-01       Impact factor: 21.596

Review 7.  Genetic Approaches to Understanding Psychiatric Disease.

Authors:  Jacob J Michaelson
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 8.  Association of Serotonin Receptors with Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis.

Authors:  Yu-Wei Hou; Ping Xiong; Xue Gu; Xin Huang; Min Wang; Jing Wu
Journal:  Curr Med Sci       Date:  2018-06-22

9.  Adult zebrafish in CNS disease modeling: a tank that's half-full, not half-empty, and still filling.

Authors:  Darya A Meshalkina; Elana V Kysil; Jason E Warnick; Konstantin A Demin; Allan V Kalueff
Journal:  Lab Anim (NY)       Date:  2017-10-06       Impact factor: 12.625

10.  Deep learning prediction of attention-deficit hyperactivity disorder in African Americans by copy number variation.

Authors:  Yichuan Liu; Hui-Qi Qu; Xiao Chang; Kenny Nguyen; Jingchun Qu; Lifeng Tian; Joseph Glessner; Patrick Ma Sleiman; Hakon Hakonarson
Journal:  Exp Biol Med (Maywood)       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.